Effects of Dopamine Infusion on Pituitary Hormone Secretion in Humans1
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Dopamine, infused at a rate of 4 mug/kg/min for 3-4 h unaccompanied by any significant changes in cardiovascular dynamics, induced a prompt and sustained suppression of circulating prolactin (PRL) levels in normal men and women as well as in patients with hyperprolactinemia. At the discontinuation of the infusion, there was a marked rebound in PRL levels in normal subjects and a rapid return to basal levels in hyperprolactinemic patients. Dopamine infusion also induced a significant fall in LH levels in the normal subjects with a marked rebound in LH levels following the infusion. No significant changes in GH, TSH, and FSH levels were observed. These data indicate that in man a dopaminergic mechanism ixists in the regulation of PRL secretion and that dopamine also exerts an inhibitory effect of LH release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies on the Mechanism of the Dopamine-Mediated Inhibition of Prolactin Secretion1
MACLEOD, R. M., & LEHMEYER, J. E. (1974) · Endocrinology · doi:10.1210/endo-94-4-1077 · Cited by 495
Odell, W. D., Rayford, P. L., & ROSS, G. T. (1967) · PubMed · Cited by 470
Disappearance Rates of Endogenous Luteinizing Hormone and Chorionic Gonadotropin in Man
YEN, S. S. C., LLERENA, O., LITTLE, B., & PEARSON, O. H. (1968) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-28-12-1763 · Cited by 373
Self-citationCyproheptadine-Induced Remission of Cushing's Disease
Krieger, D. T., Amorosa, L., & Linick, F. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510302931802 · Cited by 316
The Role of Catecholamines in the Release of Anterior Pituitary Prolactin in Vitro
SHAAR, C. J., & CLEMENS, J. A. (1974) · Endocrinology · doi:10.1210/endo-95-5-1202 · Cited by 253
THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine)
Pozo, E. D., Re, R. B. D., Varga, L., & Friesen, H. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-5-768 · Cited by 201
DOPAMINE INFUSION ACUTELY INHIBITS THE TSH AND PROLACTIN RESPONSE TO TRH
Besses, G. S., Burrow, G. N., Spaulding, S. W., Donabedian, R. K., & Pechinski, T. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-5-985 · Cited by 199
Catecholamine Inhibition of Prolactin Secretion by Isolated Rat Adenohypophyses1
BIRGE, C. A., JACOBS, L. S., HAMMER, C. T., & Daughaday, W. H. (1970) · Endocrinology · doi:10.1210/endo-86-1-120 · Cited by 199
YEN, S. S. C., LLERENA, L. A., PEARSON, O. H., & LITTELL, A. S. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-3-325 · Cited by 193
Self-citationPossible Role of Dopamine as Transmitter To Promote Discharge of LH-Releasing Factor
SCHNEIDER, H. P. G., & MCCANN, S. M. (1969) · Endocrinology · doi:10.1210/endo-85-1-121 · Cited by 182
Circulating prolactin levels during the menstrual cycle: Episodic release and diurnal variation
Ehara, Y., Siler, T., Van den Berg, G., Sinha, Y. N., & Yen, S. S. C. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(73)90069-0 · Cited by 157
Self-citationDonoso, A. O., Bishop, W. P., Fawcett, C. P., Krulich, L., & McCann, S. M. (1971) · Endocrinology · doi:10.1210/endo-89-3-774 · Cited by 155
KALRA, P. S., KALRA, S. P., KRULICH, L., FAWCETT, C. P., & McCANN, S. M. (1972) · Endocrinology · doi:10.1210/endo-90-5-1168 · Cited by 150
Functional Evaluation of Prolactin Secretion: a Guide to Therapy
Friesen, H. G., Guyda, H. J., Hwang, P., Tyson, J. E., & Barbeau, A. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106859 · Cited by 150
The Direct Demonstration of a Barrier Mechanism in the Brain Capillaries
Bertler, Å., FALCK, B., & Rosengren, E. (1964) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1964.tb01752.x · Cited by 135
Sawyer, C. H., Hilliard, J., Kanematsu, S., Scaramuzzi, R. J., & Blake, C. A. (2008) · Neuroendocrinology · doi:10.1159/000122323 · Cited by 90
Biphasic Effects of Catecholamines on Pituitary Prolactin Release in Vitro
KOCH, Y., Lu, K. H., & Meites, J. (1970) · Endocrinology · doi:10.1210/endo-87-4-673 · Cited by 75
ENDOCRINE EFFECTS OF PIMOZIDE, A SPECIFIC DOPAMINERGIC BLOCKER
COLLU, R., Jéquier, J.-C., LEBOEUF, G., et al. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-5-981 · Cited by 63
KAMBERI, I. A., Mical, R. S., & Porter, J. C. (1971) · Endocrinology · doi:10.1210/endo-89-4-1042 · Cited by 58
Further evidence for a dopamine receptor stimulating action of an ergot alkaloid
Stone, T. W. (1974) · Brain Research · doi:10.1016/0006-8993(74)90664-7 · Cited by 24
Cited by
Blood Hormones as Markers of Training Stress and Overtraining
Urhausen, A., Gabriel, H., & Kindermann, W. (1995) · Sports Medicine · doi:10.2165/00007256-199520040-00004 · Cited by 486
Reproductive Endocrine Disorders in Men With Partial Seizures of Temporal Lobe Origin
Herzog, A. G., Seibel, M. M., Schomer, D. L., Vaitukaitis, J. L., & Geschwind, N. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520040035015 · Cited by 466
Neuroendocrine Aberrations in Women With Functional Hypothalamic Amenorrhea*
BERGA, S. L., MORTOLA, J. F., GIRTON, L., SUH, B., LAUGHLIN, G., PHAM, P., & YEN, S. S. C. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-2-301 · Cited by 337
Self-citationAnterior pituitary function during critical illness and dopamine treatment
Van den Berghe, G., & de Zegher, F. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00024 · Cited by 256
ISHIZUKA, B., QUIGLEY, M. E., & YEN, S. S. C. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-6-1111 · Cited by 123
Self-citation
Metadata
- Authors
- LEBLANC, H., LACHELIN, G. C. L., ABU-FADIL, S., & YEN, S. S. C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1976-09
- Volume
- 43
- Issue
- 3
- Pages
- 668-674
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2017638447
- Cited by
- 298
- References
- 20
- FWCI
- 17.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.